statistiche ricercatore

Continente	#
NA - Nord America	607
EU - Europa	582
AS - Asia	287
SA - Sud America	94
AF - Africa	13
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.584

Nazione	#
US - Stati Uniti d'America	586
RU - Federazione Russa	327
SG - Singapore	107
BR - Brasile	81
CN - Cina	63
SE - Svezia	60
IE - Irlanda	55
IT - Italia	41
HK - Hong Kong	37
FR - Francia	22
VN - Vietnam	18
AT - Austria	16
GB - Regno Unito	13
FI - Finlandia	12
DE - Germania	11
MX - Messico	10
CA - Canada	9
TR - Turchia	9
ID - Indonesia	8
IN - India	7
NL - Olanda	7
BD - Bangladesh	5
JP - Giappone	5
IQ - Iraq	4
AR - Argentina	3
AZ - Azerbaigian	3
CO - Colombia	3
EE - Estonia	3
KR - Corea	3
PL - Polonia	3
ZA - Sudafrica	3
BG - Bulgaria	2
CH - Svizzera	2
IL - Israele	2
KH - Cambogia	2
KZ - Kazakistan	2
LU - Lussemburgo	2
MA - Marocco	2
PE - Perù	2
PH - Filippine	2
PK - Pakistan	2
SA - Arabia Saudita	2
TH - Thailandia	2
TN - Tunisia	2
TW - Taiwan	2
UY - Uruguay	2
AE - Emirati Arabi Uniti	1
BW - Botswana	1
BY - Bielorussia	1
CI - Costa d'Avorio	1
CZ - Repubblica Ceca	1
ES - Italia	1
EU - Europa	1
GY - Guiana	1
HN - Honduras	1
KE - Kenya	1
LT - Lituania	1
LV - Lettonia	1
MG - Madagascar	1
MU - Mauritius	1
PA - Panama	1
PY - Paraguay	1
SK - Slovacchia (Repubblica Slovacca)	1
SN - Senegal	1
UZ - Uzbekistan	1
VE - Venezuela	1
Totale	1.584

Nome	#
Functional inactivation of E-cadherin by Trop-2 drives cancer metastasis	302
Genomic risk for cancer activation profiles of Trop-1 and Trop-2	178
Trop-2 cleavage by ADAM10 is an activator switch for cancer growth and metastasis	154
Abstract 2851: Trop-2 inactivates E-cadherin for metastatic diffusion in the absence of EMT	147
Abstract PD15-04: Trop-2 inactivation of E-cadherin drives triple negative breast cancer relapse	146
3D-Informed Targeting of the Trop-2 Signal-Activation Site Drives Selective Cancer Vulnerability	129
Functional inactivation of E-cadherin drives EMT-less metastasis	128
Phylogenetic conservation of Trop-2 across species—rodent and primate genomics model anti-Trop-2 therapy for pre-clinical benchmarks	127
E-cadherin inactivation by Trop-2 drives EMT-less metastatic relapse in triple-negative breast cancer	126
Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer	88
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody	60
null	37
Totale	1.622

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	18	0	0	0	0	0	0	0	0	0	3	3	12
2021/2022	66	1	0	0	6	3	3	3	2	1	7	12	28
2022/2023	173	14	27	7	8	10	20	6	13	58	0	8	2
2023/2024	84	3	3	12	6	6	12	7	24	0	6	1	4
2024/2025	313	8	8	0	19	24	30	32	40	70	18	32	32
2025/2026	957	60	85	145	90	94	190	70	102	94	27	0	0
Totale													1.622